Safety Analysis of Australasian Leukaemia & Lymphoma Group Nhl29: A Phase Ii Study of Ibrutinib, Rituximab and Mini-Chop in Very Elderly Patients With Newly Diagnosed DLBCL
Hematological Oncology - United Kingdom
doi 10.1002/hon.63_2630
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Wiley